MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.280
-0.600 (-15.46%)
At close: Nov 2, 2026, 4:00 PM EST
3.350
+0.070 (2.13%)
After-hours: Nov 2, 2026, 5:58 PM EST
MiMedx Group Market Cap
MiMedx Group has a market cap or net worth of $478.64 million as of November 2, 2026. It is the 13,405th most valuable company in the world and the 2,647th biggest in the United States. Its market cap has decreased by 57.75% in one year.
Market Cap
478.64M
Enterprise Value
357.84M
1-Year Change
-57.75%
Global Rank
Country Rank
#2,647 United States
Category
ChartMarket Cap Chart
Since February 12, 2008, MiMedx Group's market cap has increased from $34.30M to $478.64M, an increase of 1,295.44%. That is a compound annual growth rate of 15.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 478.64M | -52.27% |
| Dec 31, 2025 | 1.00B | -29.07% |
| Dec 31, 2024 | 1.41B | 38.51% |
| Dec 29, 2023 | 1.02B | 222.97% |
| Dec 30, 2022 | 316.00M | -53.35% |
| Dec 31, 2021 | 677.40M | -32.82% |
| Dec 31, 2020 | 1.01B | 19.81% |
| Dec 31, 2019 | 841.60M | 323.34% |
| Dec 31, 2018 | 198.80M | -85.80% |
| Dec 29, 2017 | 1.40B | 44.30% |
| Dec 30, 2016 | 970.30M | -4.97% |
| Dec 31, 2015 | 1.02B | -17.19% |
| Dec 31, 2014 | 1.23B | 44.18% |
| Dec 31, 2013 | 855.20M | 156.74% |
| Dec 31, 2012 | 333.10M | 297.02% |
| Dec 30, 2011 | 83.90M | -2.67% |
| Dec 31, 2010 | 86.20M | 173.65% |
| Dec 31, 2009 | 31.50M | -81.05% |
| Dec 31, 2008 | 166.20M | 384.55% |
| Feb 12, 2008 | 34.30M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 532.20M |
| Shattuck Labs | 530.42M |
| Puma Biotechnology | 529.11M |
| Valneva SE | 519.43M |
| Gyre Therapeutics | 504.72M |
| Surrozen | 497.21M |
| DiaMedica Therapeutics | 496.66M |
| Oculis Holding AG | 495.09M |